Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2011BloodOpen Access

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDavide RossiOspedale di Santo SpiritoABAlessio BruscagginInstitute of Oncology ResearchVSValeria SpinaEnte Ospedaliero Cantonale

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rossi et al. (2011) studied this question.

synapsesocial.com/papers/6a11ca6eed9c06332dfd37a0https://doi.org/10.1182/blood-2011-08-373159
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The pathobiology of splicing2009 · 425 citations
  2. 2The SAPs, a New Family of Proteins, Associate and Function Positively with the SIT4 Phosphatase1996 · 165 citations
  3. 3Analysis of the chronic lymphocytic leukemia coding genome: role of <i>NOTCH1</i> mutational activation2011 · 608 citations
  4. 4Chronic Lymphocytic Leukemia2005 · 1,687 citations